INCOME RESEARCH & MANAGEMENT - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 11 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
INCOME RESEARCH & MANAGEMENT ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q3 2022$9,580,000
-18.2%
12,028,0000.0%4.50%
-10.5%
Q2 2022$11,713,000
-0.4%
12,028,0000.0%5.02%
+8.0%
Q1 2022$11,758,000
+0.2%
12,028,0000.0%4.65%
-0.4%
Q4 2021$11,730,000
-0.8%
12,028,0000.0%4.67%
-5.1%
Q3 2021$11,826,000
-0.2%
12,028,0000.0%4.92%
+12.5%
Q2 2021$11,848,000
-1.3%
12,028,0000.0%4.37%
-9.8%
Q1 2021$12,004,000
-18.3%
12,028,000
-18.6%
4.84%
-10.2%
Q4 2020$14,701,000
+1.1%
14,775,000
-1.4%
5.39%
+4.3%
Q3 2020$14,536,000
-1.2%
14,978,000
-1.4%
5.17%
-1.3%
Q2 2020$14,710,000
+3.2%
15,190,000
-2.6%
5.24%
-26.5%
Q1 2020$14,254,000
-3.2%
15,589,000
+0.3%
7.13%
+20.6%
Q4 2019$14,732,000
+5.2%
15,541,000
-0.3%
5.91%
-13.0%
Q3 2019$14,000,000
-1.8%
15,589,0000.0%6.80%
+19.7%
Q2 2019$14,254,000
-0.8%
15,589,0000.0%5.68%
+6.7%
Q1 2019$14,372,000
+2.2%
15,589,0000.0%5.32%
+13.9%
Q4 2018$14,069,000
-3.5%
15,589,0000.0%4.67%
+1.2%
Q3 2018$14,580,000
+0.9%
15,589,0000.0%4.62%
+3.6%
Q2 2018$14,449,000
+5.8%
15,589,0000.0%4.46%
+13.8%
Q1 2018$13,663,000
-32.6%
15,589,000
-32.5%
3.91%
-26.0%
Q4 2017$20,278,000
+201.1%
23,109,000
+209.3%
5.29%
+181.1%
Q3 2017$6,734,000
-16.0%
7,472,0000.0%1.88%
-13.2%
Q2 2017$8,014,000
-0.8%
7,472,000
-0.7%
2.17%
+3.2%
Q1 2017$8,077,000
-14.8%
7,522,000
-13.1%
2.10%
-0.9%
Q4 2016$9,481,000
-34.1%
8,658,000
-28.2%
2.12%
-9.6%
Q3 2016$14,384,000
+16.4%
12,056,000
+22.2%
2.34%
+6.6%
Q2 2016$12,360,000
+117.1%
9,863,000
+125.5%
2.20%
+124.8%
Q1 2016$5,692,000
-16.6%
4,374,0000.0%0.98%
-11.7%
Q4 2015$6,829,000
-51.7%
4,374,000
-58.1%
1.11%
-51.7%
Q3 2015$14,147,000
-2.9%
10,431,0000.0%2.30%
+3.6%
Q2 2015$14,577,000
-7.2%
10,431,000
-1.7%
2.22%
-17.3%
Q1 2015$15,704,000
+8.3%
10,611,0000.0%2.68%
+8.6%
Q4 2014$14,497,000
-6.0%
10,611,000
-11.7%
2.47%
+2.9%
Q3 2014$15,419,000
-9.7%
12,011,000
-10.1%
2.40%
-0.5%
Q2 2014$17,068,000
+0.7%
13,354,0000.0%2.41%
+0.2%
Q1 2014$16,951,000
+13.0%
13,354,000
+94468.4%
2.41%
-0.6%
Q4 2013$14,995,000
+0.7%
14,121
-1.7%
2.42%
-3.6%
Q3 2013$14,892,000
-1.0%
14,362
-99.9%
2.51%
-10.1%
Q2 2013$15,044,00014,362,0002.80%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q2 2021
NameSharesValueWeighting ↓
Western Asset Management Company, LLC 18,321,000$16,718,0009.03%
INCOME RESEARCH & MANAGEMENT 15,589,000$14,000,0006.80%
WHITEBOX ADVISORS LLC 16,000,000$14,487,0000.53%
Graham Capital Management, L.P. 16,525,000$15,005,0000.49%
ONTARIO TEACHERS PENSION PLAN BOARD 18,400,000$16,752,0000.30%
WESTWOOD HOLDINGS GROUP INC 29,005,000$26,516,0000.29%
Penn Capital Management Company, LLC 2,195,000$1,987,0000.21%
ADVENT CAPITAL MANAGEMENT /DE/ 10,000,000$9,128,0000.17%
Polar Capital LLP 20,663,000$18,813,0000.17%
RIVERHEAD CAPITAL MANAGEMENT LLC 5,000,000$4,529,0000.17%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders